Completed PHASE4 INTERVENTIONAL 1-arm NCT00433121

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

Discontinuation of Antipsychotics and Antidepressants Among Patients With Dementia and BPSD Living in Nursing Homes - an Open Study.

Sponsor: Demensforbundet, Norway

Conditions Dementia

Interventions Citalopram Escitalopram Haloperidole Olanzapine Quetiapin Risperidone Sertralin

Updated 5 times since 2017 Last updated: Aug 23, 2007 Started: Sep 30, 2006 Completion: Aug 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00433121, this PHASE4 trial focuses on Dementia and remains completed. Sponsored by Demensforbundet, Norway, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Demensforbundet, Norway
Sykehuset Innlandet HF

Data source: Sykehuset Innlandet HF

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ottestad, Norway